News Focus
News Focus
icon url

DewDiligence

05/04/16 10:06 AM

#201137 RE: ChikiTiny #201134

The irony is that NSTK’s business model was to develop intranasal formulations of CNS drugs. As it turned out, the intranasal technology did not work.